The report "Pyrogen Testing Market by Product
(Instruments, Services, Kits and Reagents), Application (Pharmaceutical &
Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot,
Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021"The global Pyrogen
Testing market was valued at USD 610.2 Million in 2016. This market is expected
to grow at a CAGR of 12.2% to reach USD 1086.3 Million in 2021.
Browse 74 market data Tables and 95 Figures spread through
173 Pages and in-depth TOC on "Pyrogen Testing Market”
Early buyers will receive 10% customization on this
report.
Rapidly increasing pharmaceutical and biotechnology
industries and increasing number of new biologics products launched will be the
two most important growth drivers for this market during the forecast period.
For instance, the number of new biologics products launched annually witnessed
a strong upward trend between 2003 and 2013. The number of new products
launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has
increased by 155%, from 355 treatments in 2001 to 907 in 2012. A strong
pharmaceutical product pipeline will aid the growth of the pharmaceutical and
biotechnology industry, which is an important application of pyrogen testing
products
Get The Sample Report For This Report@
The global pyrogen testing market is segmented on the basis
of applications, products, tests, and
geographies.
By application, the market is divided into
pharmaceuticals and biologicals manufacturing, medical devices manufacturing,
and other applications such as water purification, food and beverages,
cosmetics, and plastics and glass products. Of these, the pharmaceuticals and
biologicals manufacturing segment accounted for the largest share of the global
pyrogen testing market in 2016. The large share of this segment can primarily
be attributed to the rapid growth in pharmaceutical and biotechnology
industries.
The test segments included in this report
are in vitro pyrogen test, LAL (Limulus Amebocyte Lysate) test, and Rabbit
test. Of these the LAL (Limulus amebocyte lysate) test holds the highest share.
The large share of LAL test can primarily be attributed to its advantages such
as accuracy, speed, requirement of small amount of the tested sample, more
economical, and allows detection of lower level of endotoxins, and flexibility
in life science research. The LAL test is further sub-segmented in to
chromogenic tests, turbidimetric tests, and gel clot tests.
Get The
PDF Brochure For This Report@
The product segments included in the report
are kits and reagents, services, and Instruments. The kits & reagents
segment commanded the largest share of global pyrogen testing market. The large
share of this segment can mainly be attributed to repeat purchase of kits and
reagents as compared to instruments, and increasing adoption of kit-based
testing.
The geographic segments included in this
report are Asia, Europe, North America, and the Rest of the World (RoW). North
America is further segmented into the U.S. and Canada; Europe is further
segmented into France, Germany, Italy, Spain, the U.K., and the Rest of Europe
(RoE); Asia is further segmented into China, Japan, and India, and the Rest of
Asia; and the Rest of the World (RoW) is divided into Africa, Pacific and
Oceania, and South America, Central America, and the Caribbean.
Major
players in the pyrogen testing market include Associates of Cape Cod, Inc.
(U.S.) Charles River Laboratories International, Inc. (U.S.), Ellab A/S
(Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland),
Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA
Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).
About MarketsandMarkets™:
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche opportunities/threats
which will impact 70% to 80% of worldwide companies’ revenues. Currently
servicing 5000 customers worldwide including 80% of global Fortune 1000
companies as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around revenues
decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high
growth markets following the "Growth Engagement Model – GEM". The GEM
aims at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche
markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
No comments:
Post a Comment